Get our free download! Implementing AMA Style – 8 Things to Get Right

In this episode, we discuss the latest FDA approvals from June 12 –  June 16, 2023.  Here are the key highlights:

·       The FDA has granted accelerated approval to Roche's Columvi® (glofitamab) for the treatment of DLBCL and large B-cell lymphoma.

·       Linzess®  (linaclotide) capsules have been approved by the FDA to treat functional constipation in pediatric patients aged 6 to 17 years.

·       The FDA has granted premarket approval to the RECELL® autologous cell harvesting device for the treatment of vitiligo, a skin condition characterized by depigmentation.

·       Bylvay®  (odevixibat) has received FDA approval for the treatment of cholestatic pruritus in patients with Alagille syndrome.

·       The FDA has approved Eroxon®, a topical gel, as an over-the-counter treatment for erectile dysfunction.

If you need medical writing assistance please visit Nascent Medical. Nascent Medical specialize in high-quality medical writing services and they are available on call to meet your deadlines. Nascentmc.com 

Intro and outro music

Garden Of Love by Pk jazz Collective